Employees: 11-50
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| 01.06.2023 | Sortina | sortinapharma.com | - | - |
| 01.06.2023 | SACRA | sacratherapeutics.com | - | - |
| 12.05.2023 | RAPP | rappab.com | - | Sweden |
| 08.11.2022 | Henlez | henlez.com | $1M | Denmark, C... |
| 10.07.2022 | ATTGENO | attgeno.com | - | - |
| 10.07.2022 | Hoba Thera... | hobatherapeutics.com | $24.76M | Denmark |
| 29.05.2022 | Cinclus Ph... | cincluspharma.com | $26.47M | Sweden, St... |
| 17.03.2022 | Strike Pha... | strikepharma.com | - | Sweden, Up... |
| 17.03.2022 | Scenic Bio... | scenicbiotech.com | $38.39M | Netherland... |
| 14.12.2021 | ArgusEye | arguseye.se | $3.03M | Sweden, Os... |
Show more
Persons 7
| Date | First Name | Last Name | Title | Location | |||
| - | Gökçe | Günaydın,... | - | - | g***e@eirv... | - | |
| - | Stephan | Christgau,... | - | - | s*****n@ei... | - | |
| - | Morten | Meldal, Ph... | - | - | - | - | |
| - | Amanda | Hayward, P... | - | - | a*********... | - | |
| - | Magnus | Persson, M... | - | - | m*********... | - | |
| - | Lovisa | Backemar,... | - | - | l****a@eir... | - | |
| - | Tobias | Horneman-T... | - | - | t****s@eir... | - |
News 36
| Date | Title | Description |
| 05.09.2024 | Eir Ventures Invests in Purpose Pharma | - |
| 11.12.2023 | Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain | - |
| 18.10.2023 | Eir Ventures invests in Dania Tx | - |
| 10.07.2023 | Eir Ventures celebrates 3 years anniversary | - |
| 09.07.2023 | Lovisa Backemar new Principal. | - |
| 09.05.2023 | Eir invests in RAPP | - |
| 11.04.2023 | Eir invests in GutCRINE | - |
| 25.10.2022 | Eir Ventures invests in Henlez | - |
| 14.09.2022 | Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5M series A financing | - |
| 06.07.2022 | Eir Ventures invests in Hoba Therapeutics | - |
Show more
Mentions in press and media 12
| Date | Title | Description |
| 13.05.2024 | Voima Ventures co-leads a €2.8M investment round for Swedish ArgusEye | Voima Ventures co-leads a €2.8M investment round for Swedish ArgusEye 13 May, 2024, 09:03 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> The Nordic early-stage investor Voima Ventur... |
| 11.12.2023 | INDACO VENTURE PARTNERS – HOBA THERAPEUTICS RAISES EUR 23 MILLION IN A SERIES A TO ADVANCE NEW DRUG CANDIDATE AGAINST CHORNIC NEUROPATHIC PAIN | |
| 20.09.2022 | Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies | What You Should Know: Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondri... |
| 10.03.2022 | Eir Ventures leads €28M investment in Scenic Biotec | - |
| 13.12.2021 | Eir Ventures Partners Closes Life Science Venture Fund, at EUR122M | Eir Ventures Partners AB, a Stockholm, Sweden- and Copenhagen, Denmark-based life science venture capital firm, closed its fund Eir Ventures I AB, at EUR 122.3m. Launched in 2020 with support from a strong investor syndicate comprising the ... |
| 09.12.2021 | Eir Ventures Closes Life Science Venture Fund at EUR122 million | - |
| 04.10.2021 | Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro | Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google. ... |
| 13.01.2021 | Eir Ventures is delighted to announce our participation in the over subscribed €127M series B round in IO Biotech | - |
| 25.09.2020 | Eir Ventures co-leads high profile syndicate in €55 million investment in Galecto Biotech | - |
| 10.07.2020 | New €76 million VC fund Eir Ventures aims to leverage the untapped potential of health care innovation in Europe | The Life Science venture fund Eir Ventures today announced a first closing of its new fund of €76 million. With a strong base in the Nordic region and a team of experienced life science investors, Eir Ventures will invest in innovative Euro... |
Show more